🟢 Bullish Factors 1. Global Biosimilars Leader Biocon is among the world’s leading biosimilar manufacturers with products marketed across the United States, Europe, and emerging markets. The company has more than 30 biosimilars in its portfolio and continues expanding globally. 2. Weight-Loss Drug Opportunity One of the biggest growth drivers is Biocon’s planned rollout of … Read more
Overall Analyst Consensus Consensus Rating: Neutral to Outperform Analysts Covering: 30 Buy: 15 Hold: 6 Sell: 9 Average 12-Month Target: ₹7,089 Highest Target: ₹9,450 Lowest Target: ₹5,610 🟢 Bullish Analyst Opinions 1. Strong CRAMS/CDMO Growth Divi’s Laboratories is one of India’s leading Contract Research, Development & Manufacturing (CRDMO) companies. Analysts expect increasing outsourcing by global … Read more
Company Overview Marksans Pharma Ltd. (NSE: MARKSANS) is a fast-growing Indian pharmaceutical company focused on generic formulations, OTC (over-the-counter) medicines, and prescription products. The company derives a large share of its revenue from regulated markets such as the UK, US, Australia, and Europe, while steadily expanding into new international markets. Recent FY2026 results marked the … Read more
Company Overview Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) is a leading Indian pharmaceutical company with a diversified portfolio across branded formulations, generics, specialty medicines, and active pharmaceutical ingredients (APIs). The company has a strong presence in India, the US, Europe, Latin America, and emerging markets. Glenmark is also investing in respiratory, dermatology, oncology, and innovative drug … Read more
Investment Rating: Bullish (Quality Large-Cap Pharma Stock) Zydus Lifesciences is one of India’s leading pharmaceutical companies with a diversified presence across generics, specialty medicines, vaccines, biologics, consumer wellness, and contract manufacturing. The company has built a strong global footprint, particularly in the US, India, Latin America, Europe, and emerging markets. FY26 was another strong year: … Read more
Investment View: Bullish (Long-Term Compounder) Apollo Hospitals remains one of India’s highest-quality healthcare businesses with leadership across hospitals, diagnostics, pharmacies, and digital healthcare. The company’s expansion strategy, improving profitability, and rising demand for specialty healthcare continue to support long-term earnings growth. FY26 revenue grew 16% while net profit increased 34%, supported by higher occupancy, better … Read more
Live Share Price & Chart You can view the live NSE chart here: TradingView Live Chart:https://www.tradingview.com/symbols/NSE-LAURUSLABS/ NSE Quote:https://www.nseindia.com/get-quotes/equity?symbol=LAURUSLABS Laurus Labs Bullish Or Bearish = Bullish Laurus Labs Price Target In 2030 = 8000 above Company Overview Laurus Labs is one of India’s leading pharmaceutical manufacturers specializing in: Active Pharmaceutical Ingredients (API) Contract Development & Manufacturing … Read more
The Indian pharmaceutical sector continues to attract investor attention due to its defensive nature, export opportunities, and growing healthcare demand. Among the emerging pharmaceutical companies, Bliss GVS Pharma has been steadily building a strong business foundation while expanding its presence across domestic and international markets. With improving fundamentals, expanding product offerings, and growing export opportunities, … Read more